The mechanism by which it exerts its effects involves tRF3-Thr-AGT targeting the 3′ UTR of the Z-DNA-binding protein, a key regulator of inflammasome activation, leading to the degradation of ZBP1, which can activate the NLRP3 inflammasome, thereby alleviating AP and controlling disease progression. This evidence concerns the gene AGT and alkaline phosphatase measurement.